The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


PNEUMOVAX 23 solution for injection in a vial Pneumococcal Polysaccharide Vaccine



Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/055/001

Main Information

Trade NamePNEUMOVAX 23 solution for injection in a vial Pneumococcal Polysaccharide Vaccine
Active SubstancesPneumococcal vaccine
Dosage FormSolution for injection
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/055/001

Group Information

ATC CodeJ07AL Pneumococcal vaccines
J07AL01 pneumococcus, purified polysaccharides antigen

Status

License statusAuthorised
Licence Issued04/05/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC as amended.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back